We are live on ! Find out more
EVMN

Evommune Inc
EVMN

59 hedge funds and large institutions have $466M invested in Evommune Inc in 2025 Q4 according to their latest regulatory filings, with 59 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

86.29% more ownership

Funds ownership: 0% → 86.29% (+86%)

Holders
59
Holders Change
+59
Holders Change %
–
% of All Funds
0.72%
Holding in Top 10
7
Holding in Top 10 Change
+7
Holding in Top 10 Change %
% of All Funds
0.09%
New
59
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
EFM
EQT Fund Management
Luxembourg
+$92.6M
2
RCM
RA Capital Management
Massachusetts
+$65M
3
PBPIA
Pivotal bioVenture Partners Investment Advisor
California
+$36.2M
4
NFGH
Nan Fung Group Holdings
Hong Kong
+$27.1M
5
JP Morgan Chase
JP Morgan Chase
New York
+$24.6M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
EFM
1
EQT Fund Management
Luxembourg
$84.4M +$92.6M +4,929,633 New
RCM
2
RA Capital Management
Massachusetts
$59.2M +$65M +3,458,770 New
PBPIA
3
Pivotal bioVenture Partners Investment Advisor
California
$33M +$36.2M +1,926,943 New
AP
4
Andera Partners
$32.5M +$35.6M +1,897,362 New
NFGH
5
Nan Fung Group Holdings
Hong Kong
$24.7M +$27.1M +1,441,032 New
JP Morgan Chase
6
JP Morgan Chase
New York
$22.4M +$24.6M +1,308,901 New
RI
7
RTW Investments
New York
$22M +$24.1M +1,283,671 New
SCP
8
SymBiosis Capital Partners
Arkansas
$21.9M +$24.1M +1,280,778 New
Marshall Wace
9
Marshall Wace
United Kingdom
$16.9M +$18.6M +988,200 New
EAM
10
Eventide Asset Management
Massachusetts
$16.5M +$18.1M +961,525 New
T. Rowe Price Associates
11
T. Rowe Price Associates
Maryland
$13.4M +$14.7M +782,121 New
SAM
12
Sectoral Asset Management
Quebec, Canada
$10.1M +$11.1M +589,005 New
Verition Fund Management
13
Verition Fund Management
Connecticut
$9.68M +$10.6M +565,214 New
Aberdeen Group
14
Aberdeen Group
United Kingdom
$8.99M +$9.87M +525,376 New
VCIM
15
Velan Capital Investment Management
Georgia
$8.68M +$9.52M +506,754 New
Vanguard Group
16
Vanguard Group
Pennsylvania
$8.6M +$9.44M +502,574 New
OCA
17
Octagon Capital Advisors
New York
$8.56M +$9.39M +500,000 New
American Century Companies
18
American Century Companies
Missouri
$7.15M +$7.84M +417,455 New
Federated Hermes
19
Federated Hermes
Pennsylvania
$5.56M +$6.1M +325,000 New
GPP
20
Great Point Partners
Connecticut
$5.56M +$6.1M +325,000 New
NCM
21
NEXTBio Capital Management
California
$3.91M +$4.29M +228,286 New
DCM
22
Defilade Capital Management
California
$3.69M +$4.05M +215,418 New
KCM
23
Kynam Capital Management
New Jersey
$3.18M +$3.48M +185,482 New
ACM
24
ADAR1 Capital Management
Texas
$3.15M +$3.46M +184,062 New
MIM
25
Monashee Investment Management
Massachusetts
$3.14M +$3.44M +183,239 New
1
2 3

EVMN Hedge Fund Activity: Q4 2025 in Review

59 of the 8,229 institutional investors tracked by Wall St. Rank reported a position in Evommune Inc (EVMN) for Q4 2025, worth a combined $466M.

Buyers outnumbered sellers: 59 funds opened new EVMN positions and 0 closed out — a net gain of 59 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was EQT Fund Management, opening a new position worth an estimated $92.6M.

  • 59 institutional investors held Evommune Inc (EVMN) as of Q4 2025, up from 0 in Q3 2025.
  • Funds reported $466M of Evommune Inc stock for Q4 2025.
  • 59 funds opened new Evommune Inc positions in Q4 2025 and 0 closed out, a net change of +59 holders.
  • The largest Evommune Inc buyer in Q4 2025 was EQT Fund Management, an estimated $92.6M added.

Based on aggregated 13F filings for Q4 2025.